{"id":390330,"date":"2020-12-01T07:03:24","date_gmt":"2020-12-01T12:03:24","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=390330"},"modified":"2020-12-01T07:03:24","modified_gmt":"2020-12-01T12:03:24","slug":"achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/","title":{"rendered":"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <strong>Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Stevenage, UK 1 December 2020<\/strong> \u2013 Achilles Therapeutics (\u201cAchilles\u201d), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat multiple types of solid tumours, today announced the appointment of\u00a0Robert Coutts as Chief Financial Officer. Robert has served as Finance Director at Achilles since the Company\u2019s formation in 2017.<\/p>\n<p align=\"justify\">\u201cRobert has been part of the Achilles team since the beginning and I\u2019m delighted to welcome him to his new role,\u201d<strong> said Dr. Iraj Ali, CEO of Achilles Therapeutics<\/strong>. &#8220;Robert has deep expertise in building and developing operating businesses. His experience, leadership and commitment to the Company will be integral as our potentially transformative precision TIL therapy progresses in the clinic in multiple solid tumor indications.\u201d<\/p>\n<p align=\"justify\">\u201cI have been fortunate enough to be a part of the Company&#8217;s evolution over the last few years, and I look forward to continuing to support Iraj, the management team and Board in our efforts to develop much needed novel cancer therapies for patients,\u201d <strong>said Robert Coutts, CFO of Achilles Therapeutics.<\/strong> \u201cAs the Company continues to advance its pipeline, the finance function will be an important strategic partner across the Company, including research and development, manufacturing and clinical operations.&#8221;<\/p>\n<p align=\"justify\">Prior to joining Achilles, Robert worked for Syncona Ltd leading the finance functions of new entities within its life science portfolio. He previously served in roles of increasing responsibility at the Wellcome Trust. Robert qualified as a chartered accountant with KPMG where he spent time in both their Audit and Transactions &amp; Restructuring teams. He has an MSc in Management from Cass Business School and a BA in Politics, Philosophy and Economics from Oxford University.<\/p>\n<p align=\"center\">\u2013 Ends \u2013<\/p>\n<p>\n        <strong>Notes for Editors:<\/strong>\n      <\/p>\n<p>\n        <strong>About Achilles Therapeutics<\/strong>\n      <\/p>\n<p align=\"justify\">Achilles Therapeutics is a clinical stage, biopharmaceutical company developing precision T cell therapies targeting clonal neoantigens: protein markers unique to the individual that are expressed on the surface of every cancer cell. The Company has two ongoing Phase I\/IIa trials, the CHIRON trial in patients with advanced non-small cell lung cancer (NSCLC) and the THETIS trial in patients with recurrent or metastatic malignant melanoma. Achilles uses DNA sequencing data from each patient, together with the proprietary PELEUS\u2122 bioinformatics platform, to identify clonal neoantigens specific to that patient, and then develop personalised T cell-based therapies specifically targeting those clonal neoantigens.<\/p>\n<p align=\"justify\">For further information please visit the Company\u2019s website at:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ga57A4k0b795GKuwXwyRMFJgdJwtZ6PXJKdvWxhA6cUBSCLU8aSv0JtAt-H_k44H5UdEecPxcpqPxixI-FX6odjZhlHuAQs_EE6LK5MXBo0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.achillestx.com<\/a><u>. <\/u><\/p>\n<p>\n        <strong>Further information:<\/strong>\n      <\/p>\n<p>\n        <strong>Achilles Therapeutics<\/strong><br \/>\n        <br \/> Dr Iraj Ali \u2013 Chief Executive Officer<br \/> +44 (0)1438 906 906<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pyLZ7C3X2Ys9OOMCDx4sWqkavBpo865IHfcm8N5Xj0GH2EwTP17vD9afzVj4xT5B-bC-XTA-A0vbQmAojb2KIuL6KfLjZTba0_wU2yGrHS4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>media@achillestx.com<\/u><\/a><\/p>\n<p>\n        <strong>Julia Wilson \u2013 Head of Communications<\/strong><br \/>\n        <br \/> +44 (0)7818 430877<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y1yA-Zt7aEodOcvJoTpZlGWQnNnUm3G-A_z7BWBZpU4tdyfQY4K92jxKOs-2FHoRFbRl1stmQpp5x003GCpwerAVyLddkXZ-AlZi431I__c=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>j.wilson@achillestx.com<\/u><\/a><\/p>\n<p>\n        <strong>Consilium Strategic Communications<\/strong><br \/>\n        <br \/> Mary-Jane Elliott, Sukaina Virji, Melissa Gardiner<br \/> +44 (0) 203 709 5000<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_RxfRLrmmH9s_Ushr_JwN3nVPpdII7iTUcFmoyvtfx9YrrVc5hJMjP5joZHT9KVxQCSKeW1nIH-UvRa6vjjnVtqYcvBhjSJBJJOqFdosJXVUm2tuAc4_Jv3oxpvR5UF9\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>achillestx@consilium-comms.com<\/u><\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzI4NCM0MDA4MzEwNTgjNzAwMDExMzIz\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/release\/track\/1d664192-fb70-4e91-b84c-9536363ca89a\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer Stevenage, UK 1 December 2020 \u2013 Achilles Therapeutics (\u201cAchilles\u201d), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat multiple types of solid tumours, today announced the appointment of\u00a0Robert Coutts as Chief Financial Officer. Robert has served as Finance Director at Achilles since the Company\u2019s formation in 2017. \u201cRobert has been part of the Achilles team since the beginning and I\u2019m delighted to welcome him to his new role,\u201d said Dr. Iraj Ali, CEO of Achilles Therapeutics. &#8220;Robert has deep expertise in building and developing operating businesses. His experience, leadership and commitment to the Company will be integral as our potentially transformative precision TIL therapy progresses in the clinic in &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-390330","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer Stevenage, UK 1 December 2020 \u2013 Achilles Therapeutics (\u201cAchilles\u201d), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat multiple types of solid tumours, today announced the appointment of\u00a0Robert Coutts as Chief Financial Officer. Robert has served as Finance Director at Achilles since the Company\u2019s formation in 2017. \u201cRobert has been part of the Achilles team since the beginning and I\u2019m delighted to welcome him to his new role,\u201d said Dr. Iraj Ali, CEO of Achilles Therapeutics. &#8220;Robert has deep expertise in building and developing operating businesses. His experience, leadership and commitment to the Company will be integral as our potentially transformative precision TIL therapy progresses in the clinic in &hellip; Continue reading &quot;Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-01T12:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzI4NCM0MDA4MzEwNTgjNzAwMDExMzIz\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer\",\"datePublished\":\"2020-12-01T12:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/\"},\"wordCount\":441,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0MzI4NCM0MDA4MzEwNTgjNzAwMDExMzIz\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/\",\"name\":\"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0MzI4NCM0MDA4MzEwNTgjNzAwMDExMzIz\",\"datePublished\":\"2020-12-01T12:03:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0MzI4NCM0MDA4MzEwNTgjNzAwMDExMzIz\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0MzI4NCM0MDA4MzEwNTgjNzAwMDExMzIz\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/","og_locale":"en_US","og_type":"article","og_title":"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer - Market Newsdesk","og_description":"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer Stevenage, UK 1 December 2020 \u2013 Achilles Therapeutics (\u201cAchilles\u201d), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat multiple types of solid tumours, today announced the appointment of\u00a0Robert Coutts as Chief Financial Officer. Robert has served as Finance Director at Achilles since the Company\u2019s formation in 2017. \u201cRobert has been part of the Achilles team since the beginning and I\u2019m delighted to welcome him to his new role,\u201d said Dr. Iraj Ali, CEO of Achilles Therapeutics. &#8220;Robert has deep expertise in building and developing operating businesses. His experience, leadership and commitment to the Company will be integral as our potentially transformative precision TIL therapy progresses in the clinic in &hellip; Continue reading \"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-01T12:03:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzI4NCM0MDA4MzEwNTgjNzAwMDExMzIz","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer","datePublished":"2020-12-01T12:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/"},"wordCount":441,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzI4NCM0MDA4MzEwNTgjNzAwMDExMzIz","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/","name":"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzI4NCM0MDA4MzEwNTgjNzAwMDExMzIz","datePublished":"2020-12-01T12:03:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzI4NCM0MDA4MzEwNTgjNzAwMDExMzIz","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzI4NCM0MDA4MzEwNTgjNzAwMDExMzIz"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/achilles-therapeutics-appoints-robert-coutts-as-chief-financial-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/390330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=390330"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/390330\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=390330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=390330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=390330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}